These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35420035)

  • 1. NIR-II Navigation with an EGFR-Targeted Probe Improves Imaging Resolution and Sensitivity of Detecting Micrometastases in Esophageal Squamous Cell Carcinoma Xenograft Models.
    Wang L; Liang M; Xiao Y; Chen J; Mei C; Lin Y; Zhang Y; Li D
    Mol Pharm; 2022 Oct; 19(10):3563-3575. PubMed ID: 35420035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model.
    Liang M; Yang M; Wang F; Wang X; He B; Mei C; He J; Lin Y; Cao Q; Li D; Shan H
    J Control Release; 2021 Apr; 332():171-183. PubMed ID: 33636245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes.
    Liang M; Wang L; Xiao Y; Yang M; Mei C; Zhang Y; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2787-2801. PubMed ID: 37145165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma.
    Shu W; Xiao Y; Wang L; Liang M; Li Z; Wu X; Cao Q
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice.
    Ma W; Ma L; Zhe H; Bao C; Wang N; Yang S; Wang K; Cao F; Cheng Y; Cheng Y
    PLoS One; 2014; 9(3):e92351. PubMed ID: 24618814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3 expression in esophageal squamous cell carcinoma : Implications for cetuximab sensitivity and therapeutic strategies.
    Wu S; Wang Y; Xiao Z; Zhang J; He Z; Ye M
    Wien Klin Wochenschr; 2024 Jun; 136(11-12):331-339. PubMed ID: 37874348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
    Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
    Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
    Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
    Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to cetuximab in EGFR-overexpressing esophageal squamous cell carcinoma xenografts due to FGFR2 amplification and overexpression.
    Zhang Y; Pan T; Zhong X; Cheng C
    J Pharmacol Sci; 2014; 126(1):77-83. PubMed ID: 25242085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines.
    Fukuoka S; Kojima T; Koga Y; Yamauchi M; Komatsu M; Komatsuzaki R; Sasaki H; Yasunaga M; Matsumura Y; Doi T; Ohtsu A
    Oncotarget; 2017 Feb; 8(7):11020-11029. PubMed ID: 28038457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
    Gong JH; Liu XJ; Li Y; Zhen YS
    Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma.
    Li X; Zhang L; Guo X; Xie F; Shen C; Jun Y; Luo C; Liu L; Yu X; Zhang Z; Wang Q; Gao Y; Xu K
    J Nanobiotechnology; 2021 Nov; 19(1):388. PubMed ID: 34823537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.